The 15 most promising drug companies

Want a peek at the future of the industry? Our sister publication FierceBiotech has released its pick of the top 15 companies at the forefront of drug development. We here at FiercePharma don't usually cover the development side of things, but its worth taking a look to see which companies are on the cutting edge of the field. Biotech is a risky game and while not all of these companies will be as successful as they hope to be, you can bet at least a few on the list will make headlines as future acquisition targets or IPO-stage companies with commercial opportunities to pursue. Click here to see the 2008 Fierce 15 winners. List

Free Webinar

What could you do with real-time supply chain information at your fingertips?

Interested in complete supply chain real-time data visibility? Unlock productivity with digital workflows, manage plants inventory with real-time supply chain information and enable faster decision-making with data visualization with pci | bridge. Register today!

Suggested Articles

Implementing data integration strategy in your commercialization breaks down traditional healthcare silos and improves patient outcomes.

Roche and Blueprint's RET inhibitor Gavreto has won FDA go-ahead to treat certain types of thyroid cancer, leveling the field with Lilly's Retevmo.

CDMO Sterling Pharma Solutions is plotting a buyout of a U.K.-based antibody-drug conjugate specialist in a new bid at the next-gen cancer fighters.